Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C

Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

(2012) Bruno Sainz et al.   NATURE MEDICINE

Polymorphisms of Hepatitis C Virus Non-Structural Protein 5A and Core Protein and Clinical Outcome of Pegylated-Interferon/Ribavirin Combination Therapy

(2011) Ahmed El-Shamy et al.   INTERVIROLOGY

Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus

(2011) M. Yamamoto et al.   JOURNAL OF GENERAL VIROLOGY

Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study

(2011) Masahiko Shimada et al.   JOURNAL OF HEPATOLOGY

Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy

(2011) Takahiro Azakami et al.   JOURNAL OF MEDICAL VIROLOGY

Expression profiles of genes associated with viral entry in HCV-infected human liver

(2011) M. Nakamuta et al.   JOURNAL OF MEDICAL VIROLOGY

Characterization of HCV Interactions with Toll-Like Receptors and RIG-I in Liver Cells

(2011) Erika A. Eksioglu et al.   PLoS One

Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity

(2011) Helene Minyi Liu et al.   Gastroenterology Research and Practice

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

(2010) C. N. Hayes et al.   GUT

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

(2010) Stephen A. Harrison et al.   HEPATOLOGY

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

(2010) Norio Akuta et al.   HEPATOLOGY

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

(2010) Alexander J. Thompson et al.   HEPATOLOGY

Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir

(2010) Fumitaka Suzuki et al.   HEPATOLOGY

Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver

(2010) Tatsuya Fujino et al.   HEPATOLOGY RESEARCH

Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus

(2010) Stanley M. Lemon   JOURNAL OF BIOLOGICAL CHEMISTRY

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C

(2010) Jacques Fellay et al.   NATURE

An antioxidant resveratrol significantly enhanced replication of hepatitis C virus

(2010) Mitsuyasu Nakamura   WORLD JOURNAL OF GASTROENTEROLOGY

Pegylated IFN-α2a and ribavirin in the treatment of hepatitis C

(2009) Alessio Aghemo et al.   Expert Review of Anti-Infective Therapy

Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes

(2009) Hashem B. El–Serag et al.   GASTROENTEROLOGY

An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

(2009) Hitomi Sezaki et al.   INTERVIROLOGY

Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease

(2009) Loubna Jouan et al.   JOURNAL OF HEPATOLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction

(2009) Shingo Nakamoto et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fluvastatin Inhibits Hepatitis C Replication in Humans

(2008) Ted Bader et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells

(2008) Motoyuki Kohjima et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

MAVS Dimer Is a Crucial Signaling Component of Innate Immunity and the Target of Hepatitis C Virus NS3/4A Protease

(2008) M. Baril et al.   JOURNAL OF VIROLOGY

Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR

(2007) Caroline Scholtes et al.   JOURNAL OF HEPATOLOGY